Tanke Biosciences Corporation
TNBI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$120 | -$83 | -$98 | -$723 |
| Dep. & Amort. | $1 | $9 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $663 |
| Change in WC | $84 | $20 | $3 | $2 |
| Other Non-Cash | $0 | -$20 | $36 | $55 |
| Operating Cash Flow | -$35 | -$75 | -$59 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $70 | $25 | $0 |
| Stock Issued | $4 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28 | $0 | $0 | $45 |
| Financing Cash Flow | $32 | $70 | $25 | $45 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$5 | -$34 | $41 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3 | $7 | $41 | $0 |
| End Cash | $0 | $3 | $7 | $41 |
| Free Cash Flow | -$35 | -$75 | -$59 | -$4 |